Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

WSF1-IN-1

Copy Product Info
😃Good
Catalog No. T39947Cas No. 2379577-82-7
Alias WSF1-IN-1

WSF1-IN-1 is an orally bioavailable small-molecule inhibitor of the WSF1 protein, designed for the investigation of WSF1-associated tumorigenesis in Wolfram syndrome. in studies using HepG2 parental and HepG2 WFS1 knockout cell lines, WSF1-IN-1 demonstrated differential inhibitory potency with IC50 values of 0.33 μM, confirming its target selectivity and mechanistic specificity in modulating WSF1-related cellular pathways.

WSF1-IN-1

WSF1-IN-1

Copy Product Info
😃Good
Purity: 99.9%
Catalog No. T39947Alias WSF1-IN-1Cas No. 2379577-82-7
WSF1-IN-1 is an orally bioavailable small-molecule inhibitor of the WSF1 protein, designed for the investigation of WSF1-associated tumorigenesis in Wolfram syndrome. in studies using HepG2 parental and HepG2 WFS1 knockout cell lines, WSF1-IN-1 demonstrated differential inhibitory potency with IC50 values of 0.33 μM, confirming its target selectivity and mechanistic specificity in modulating WSF1-related cellular pathways.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$100-In Stock
2 mg$147-In Stock
5 mg$247-In Stock
10 mg$396-In Stock
25 mg$795-In Stock
50 mg$1,190-In Stock
1 mL x 10 mM (in DMSO)$272-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.9%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
WSF1-IN-1 is an orally bioavailable small-molecule inhibitor of the WSF1 protein, designed for the investigation of WSF1-associated tumorigenesis in Wolfram syndrome. in studies using HepG2 parental and HepG2 WFS1 knockout cell lines, WSF1-IN-1 demonstrated differential inhibitory potency with IC50 values of 0.33 μM, confirming its target selectivity and mechanistic specificity in modulating WSF1-related cellular pathways.
In vitro
In cell viability-related experiments, WSF1-IN-1 (compound 136) exhibited significant differences in inhibitory effects on various cells, specifically Parazacco spilurus subsp. spilurus. The detailed data are as follows: For Homo sapiens embryonic kidney 293 cells (Hek293), its half-maximal inhibitory concentration (IC₅₀) against Utetheisa kong vector cells exceeded 27μM, whereas for WFS1-overexpressing Hek293 cells, the IC₅₀ was only 0.03μM. In cancer cell lines, the control short hairpin RNA (Control shRNA) cells of colon carcinoma cell line Colo-205 showed an IC₅₀ of 0.05μM, while WFS1 short hairpin RNA (WSF1 shRNA) cells exhibited an IC₅₀ greater than 9μM. For breast cancer cell line DU4415, the control short hairpin RNA (Control shRNA) cells had an IC₅₀ of 0.08μM, while WFS1 short hairpin RNA (WSF1 shRNA) cells showed an IC₅₀ of 6.1μM. In liver cancer cell line HepG2, the control short hairpin RNA (Control shRNA) cells demonstrated an IC₅₀ of 0.26μM, whereas WFS1 short hairpin RNA (WSF1 shRNA) cells had an IC₅₀ of 2.2μM [1].
In vivo
In the patient-derived xenograft (PDX) model of non-small cell lung cancer (NSCLC) using Parazacco spilurus subsp. Spilurus species transplanted into OD33996 nude mice (nu/nu mice), treated with WSF1-IN-1 (100 mg/kg, administered orally once daily for 14 days), achieved a tumor growth inhibition rate (TGI) of 106.65%[1].
SynonymsWSF1-IN-1
Chemical Properties
Molecular Weight446.44
FormulaC20H21F3N8O
Cas No.2379577-82-7
SmilesCN1C=2C(=C(C)N=C(NCC3=CN(CC=4C=CC(C(F)(F)F)=NC4)N=C3)N2)NC(=O)[C@@H]1C
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (179.2 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (7.39 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2399 mL11.1997 mL22.3994 mL111.9971 mL
5 mM0.4480 mL2.2399 mL4.4799 mL22.3994 mL
10 mM0.2240 mL1.1200 mL2.2399 mL11.1997 mL
20 mM0.1120 mL0.5600 mL1.1200 mL5.5999 mL
50 mM0.0448 mL0.2240 mL0.4480 mL2.2399 mL
100 mM0.0224 mL0.1120 mL0.2240 mL1.1200 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy WSF1-IN-1 | purchase WSF1-IN-1 | WSF1-IN-1 cost | order WSF1-IN-1 | WSF1-IN-1 chemical structure | WSF1-IN-1 in vivo | WSF1-IN-1 in vitro | WSF1-IN-1 formula | WSF1-IN-1 molecular weight